399 related articles for article (PubMed ID: 18795918)
21. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
[TBL] [Abstract][Full Text] [Related]
22. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
23. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
[TBL] [Abstract][Full Text] [Related]
24. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
Kawashima M;
Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
27. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment.
Oshio T; Sasaki Y; Funakoshi-Tago M; Aizu-Yokota E; Sonoda Y; Matsuoka H; Kasahara T
Int Immunopharmacol; 2009 Apr; 9(4):403-11. PubMed ID: 19162238
[TBL] [Abstract][Full Text] [Related]
28. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
29. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.
Korting HC; Schöllmann C
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):133-40. PubMed ID: 21977914
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
31. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis.
Lee JH; Lee SJ; Kim D; Bang D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1360-8. PubMed ID: 17958842
[TBL] [Abstract][Full Text] [Related]
32. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
Patel RR; Vander Straten MR; Korman NJ
Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
[TBL] [Abstract][Full Text] [Related]
34. Topical fluticasone propionate lotion does not cause HPA axis suppression.
Hebert AA; Friedlander SF; Allen DB
J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
[TBL] [Abstract][Full Text] [Related]
35. Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC/Nga mice.
Sasakawa T; Higashi Y; Sakuma S; Hirayama Y; Sasakawa Y; Ohkubo Y; Mutoh S
Int Arch Allergy Immunol; 2004 Jan; 133(1):55-63. PubMed ID: 14726632
[TBL] [Abstract][Full Text] [Related]
36. Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis.
Xhauflaire-Uhoda E; Thirion L; Piérard-Franchimont C; Piérard GE
Dermatology; 2007; 214(4):328-32. PubMed ID: 17460405
[TBL] [Abstract][Full Text] [Related]
37. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
39. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.
Berth-Jones J; Damstra RJ; Golsch S; Livden JK; Van Hooteghem O; Allegra F; Parker CA;
BMJ; 2003 Jun; 326(7403):1367. PubMed ID: 12816824
[TBL] [Abstract][Full Text] [Related]
40. Wet-wrap therapy with halometasone cream for severe adult atopic dermatitis.
Xu W; Li Y; Chen Z; Liu T; Wang S; Li L
Postgrad Med; 2018 Jun; 130(5):470-476. PubMed ID: 29768078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
